Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tateishi, J.
Right arrow Articles by Furukawa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tateishi, J.
Right arrow Articles by Furukawa, H.
NEUROLOGY 1996;46:532-537
© 1996 American Academy of Neurology

Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents

J. Tateishi, MD, T. Kitamoto, MD, M. Z. Hoque, MD and H. Furukawa, MD

From the Department of Neuropathology, Neurological Institute, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Supported by grants from the Science and Technology Agency, Japan, and the Ministry of Education, Science and Culture, Japan.
Received December 12, 1994. Accepted in final form April 20, 1995.
Address correspondence and reprint requests to Dr. Jun Tateishi, Department of Neuropathology, Neurological Institute, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka 812, Japan.

Sporadic Creutzfeldt-Jakob disease (CJD) with 129M/M, and iatrogenic and familial CJD with E200K and M232R, showed similar clinicopathologic features, a synaptic type deposition of PrPCJD, and high transmission frequencies to mice. Sporadic patients with 129M/V or 129V/V, and mutation cases with V180I, showed slightly different features and low or null transmission frequencies to mice. Hereditary cases with P102L, P105L, A117V, Y145stop, and insertions had different features but all demonstrated a long clinical duration and the presence of PrP plaques. The experimental transmission to mice of these mutant forms was difficult, except for one-third of the cases with P102L. CJD and related diseases, even those that are hereditary, may thus be divided into two different groups, those that are easily transmissible and those that are either difficult to transmit or nontransmissible.

NEUROLOGY 1996,46 532-537




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
E. A. Asante, I. Gowland, A. Grimshaw, J. M. Linehan, M. Smidak, R. Houghton, O. Osiguwa, A. Tomlinson, S. Joiner, S. Brandner, et al.
Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins
J. Gen. Virol., March 1, 2009; 90(3): 546 - 558.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. M. H. Tank, D. A. Harris, A. A. Desai, and H. L. True
Prion Protein Repeat Expansion Results in Increased Aggregation and Reveals Phenotypic Variability
Mol. Cell. Biol., August 1, 2007; 27(15): 5445 - 5455.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Piccardo, J. C. Manson, D. King, B. Ghetti, and R. M. Barron
Accumulation of prion protein in the brain that is not associated with transmissible disease
PNAS, March 13, 2007; 104(11): 4712 - 4717.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Le Dur, V. Beringue, O. Andreoletti, F. Reine, T. L. Lai, T. Baron, B. Bratberg, J.-L. Vilotte, P. Sarradin, S. L. Benestad, et al.
A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes
PNAS, November 1, 2005; 102(44): 16031 - 16036.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Tremblay, H. L. Ball, K. Kaneko, D. Groth, R. S. Hegde, F. E. Cohen, S. J. DeArmond, S. B. Prusiner, and J. G. Safar
Mutant PrPSc Conformers Induced by a Synthetic Peptide and Several Prion Strains
J. Virol., February 15, 2004; 78(4): 2088 - 2099.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Kundu, N. R. Maiti, E. M. Jones, K. A. Surewicz, D. L. Vanik, and W. K. Surewicz
Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: Structural clues for prion propagation
PNAS, October 14, 2003; 100(21): 12069 - 12074.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Chiesa, P. Piccardo, E. Quaglio, B. Drisaldi, S. L. Si-Hoe, M. Takao, B. Ghetti, and D. A. Harris
Molecular Distinction between Pathogenic and Infectious Properties of the Prion Protein
J. Virol., July 1, 2003; 77(13): 7611 - 7622.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
C Weissmann and E Flechsig
PrP knock-out and PrP transgenic mice in prion research
Br. Med. Bull., June 1, 2003; 66(1): 43 - 60.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
L. Manuelidis, W. Fritch, and Y. Xi
Evolution of a Strain of CJD That Induces BSE-Like Plaques
Science, July 4, 1997; 277(5322): 94 - 98.
[Abstract] [Full Text]


Home page
Cold Spring Harb Symp Quant BiolHome page
S.B. Prusiner
Molecular Biology and Genetics of Prion Diseases
Cold Spring Harb Symp Quant Biol, January 1, 1996; 61(0): 473 - 493.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
R. S. Stewart and D. A. Harris
Most Pathogenic Mutations Do Not Alter the Membrane Topology of the Prion Protein
J. Biol. Chem., January 12, 2001; 276(3): 2212 - 2220.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by AAN Enterprises, Inc.